“CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY”. 2026. PharmaNexus Bulletin 2 (2): 1-5. https://lapinjournals.com/index.php/pnb/article/view/208.